[Recent developments in the treatment of chronic hepatitis B and C]. / Recente ontwikkelingen in de behandeling van chronische hepatitis B en C.
Ned Tijdschr Tandheelkd
; 114(8): 353-6, 2007 Aug.
Article
in Nl
| MEDLINE
| ID: mdl-17822245
ABSTRACT
Chronic hepatitis B and C are life-threatening diseases, treated with variable success. Peginterferon-alpha is one of the standard therapies for chronic hepatitis B as well as C. To prevent the development of resistant viruses, combination treatment is preferable to monotherapy. Therefore, in chronic hepatitis B virus peginterferon-alpha combined with nucleoside inhibitors is used. The treatment of chronic hepatitis C virus with a combination of peginterferon-alpha and ribavirine can be improved by new protease inhibitors.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Hepatitis B, Chronic
/
Hepatitis C, Chronic
Limits:
Humans
Language:
Nl
Journal:
Ned Tijdschr Tandheelkd
Year:
2007
Type:
Article